Balticidin D
| Internal ID | b3ef5128-4059-4055-8de3-a882ae9eea24 |
| Taxonomy | Organic acids and derivatives > Peptidomimetics > Depsipeptides > Cyclic depsipeptides > Cyclic glycodepsipeptides |
| IUPAC Name | (2R,3S,4R,5S,6S)-6-[(2S,3S,4R,5R)-2-[1-[[1-[[(3R,12S,15Z)-3,12-bis(3-amino-3-oxopropyl)-15-ethylidene-21-(1-hydroxyethyl)-18-[hydroxy-(4-hydroxyphenyl)methyl]-7,25-dimethyl-2,5,8,11,14,17,20,23-octaoxo-6-[1-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]-1-oxa-4,7,10,13,16,19,22-heptazacyclopentacos-24-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-2-hydroxy-1-oxohexadecan-3-yl]oxy-3,5-dihydroxyoxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C75H119N11O35/c1-8-10-11-12-13-14-15-16-17-18-19-20-42(118-73-60(103)61(41(91)31-115-73)120-75-59(102)56(99)57(100)62(121-75)71(112)113)54(97)70(111)83-48(33(4)89)65(106)84-49-34(5)116-72(114)40(26-28-45(77)93)81-69(110)51(35(6)117-74-58(101)55(98)53(96)43(30-87)119-74)86(7)46(94)29-78-63(104)39(25-27-44(76)92)80-64(105)38(9-2)79-68(109)50(52(95)36-21-23-37(90)24-22-36)85-66(107)47(32(3)88)82-67(49)108/h9,21-24,32-35,39-43,47-62,73-75,87-91,95-103H,8,10-20,25-31H2,1-7H3,(H2,76,92)(H2,77,93)(H,78,104)(H,79,109)(H,80,105)(H,81,110)(H,82,108)(H,83,111)(H,84,106)(H,85,107)(H,112,113)/b38-9-/t32?,33?,34?,35?,39-,40+,41+,42?,43-,47?,48?,49?,50?,51?,52?,53-,54?,55+,56+,57-,58+,59-,60-,61+,62+,73-,74-,75-/m0/s1 |
| InChI Key | SVWZKSCWSWYLPR-GGBPWVLZSA-N |
| Popularity | 4 references in papers |
| Molecular Formula | C75H119N11O35 |
| Molecular Weight | 1734.80 g/mol |
| Exact Mass | 1733.7870045 g/mol |
| Topological Polar Surface Area (TPSA) | 741.00 Ų |
| XlogP | -3.50 |
| Atomic LogP (AlogP) | -9.46 |
| H-Bond Acceptor | 34 |
| H-Bond Donor | 25 |
| Rotatable Bonds | 36 |
| DTXSID301334477 |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | - | 0.7416 | 74.16% |
| Caco-2 | - | 0.8583 | 85.83% |
| Blood Brain Barrier | - | 0.9500 | 95.00% |
| Human oral bioavailability | - | 0.7429 | 74.29% |
| Subcellular localzation | Mitochondria | 0.4243 | 42.43% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.7960 | 79.60% |
| OATP1B3 inhibitior | + | 0.9189 | 91.89% |
| MATE1 inhibitior | - | 0.9600 | 96.00% |
| OCT2 inhibitior | - | 0.9500 | 95.00% |
| BSEP inhibitior | + | 0.9515 | 95.15% |
| P-glycoprotein inhibitior | + | 0.7417 | 74.17% |
| P-glycoprotein substrate | + | 0.8714 | 87.14% |
| CYP3A4 substrate | + | 0.7592 | 75.92% |
| CYP2C9 substrate | - | 1.0000 | 100.00% |
| CYP2D6 substrate | - | 0.8711 | 87.11% |
| CYP3A4 inhibition | + | 0.5066 | 50.66% |
| CYP2C9 inhibition | - | 0.8211 | 82.11% |
| CYP2C19 inhibition | - | 0.9061 | 90.61% |
| CYP2D6 inhibition | - | 0.8200 | 82.00% |
| CYP1A2 inhibition | - | 0.8897 | 88.97% |
| CYP2C8 inhibition | + | 0.8452 | 84.52% |
| CYP inhibitory promiscuity | - | 0.9493 | 94.93% |
| UGT catelyzed | - | 0.6000 | 60.00% |
| Carcinogenicity (binary) | - | 0.9200 | 92.00% |
| Carcinogenicity (trinary) | Non-required | 0.5685 | 56.85% |
| Eye corrosion | - | 0.9859 | 98.59% |
| Eye irritation | - | 0.8953 | 89.53% |
| Skin irritation | - | 0.7614 | 76.14% |
| Skin corrosion | - | 0.9280 | 92.80% |
| Ames mutagenesis | - | 0.6456 | 64.56% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.7290 | 72.90% |
| Micronuclear | + | 0.8900 | 89.00% |
| Hepatotoxicity | - | 0.6587 | 65.87% |
| skin sensitisation | - | 0.8693 | 86.93% |
| Respiratory toxicity | + | 0.7667 | 76.67% |
| Reproductive toxicity | + | 0.9111 | 91.11% |
| Mitochondrial toxicity | + | 0.9000 | 90.00% |
| Nephrotoxicity | - | 0.8940 | 89.40% |
| Acute Oral Toxicity (c) | III | 0.6485 | 64.85% |
| Estrogen receptor binding | - | 0.5000 | 50.00% |
| Androgen receptor binding | + | 0.7525 | 75.25% |
| Thyroid receptor binding | + | 0.7986 | 79.86% |
| Glucocorticoid receptor binding | + | 0.8406 | 84.06% |
| Aromatase binding | + | 0.8054 | 80.54% |
| PPAR gamma | + | 0.7883 | 78.83% |
| Honey bee toxicity | - | 0.6104 | 61.04% |
| Biodegradation | - | 0.8000 | 80.00% |
| Crustacea aquatic toxicity | - | 0.5052 | 50.52% |
| Fish aquatic toxicity | + | 0.8247 | 82.47% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL4040 | P28482 | MAP kinase ERK2 | 100.00% | 83.82% |
| CHEMBL2581 | P07339 | Cathepsin D | 99.59% | 98.95% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 99.59% | 91.11% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.28% | 96.09% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 96.03% | 94.45% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 95.94% | 99.17% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 95.83% | 93.10% |
| CHEMBL3837 | P07711 | Cathepsin L | 95.55% | 96.61% |
| CHEMBL2345 | P51812 | Ribosomal protein S6 kinase alpha 3 | 95.30% | 95.64% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 94.87% | 89.00% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 94.38% | 93.56% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 93.74% | 95.56% |
| CHEMBL5469 | Q14289 | Protein tyrosine kinase 2 beta | 93.61% | 91.03% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 93.30% | 100.00% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 92.69% | 90.08% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 91.69% | 100.00% |
| CHEMBL2955 | O95136 | Sphingosine 1-phosphate receptor Edg-5 | 91.61% | 92.86% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 91.59% | 95.89% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 91.47% | 100.00% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 91.45% | 94.66% |
| CHEMBL226 | P30542 | Adenosine A1 receptor | 91.41% | 95.93% |
| CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 90.56% | 99.23% |
| CHEMBL5852 | Q96P65 | Pyroglutamylated RFamide peptide receptor | 90.09% | 85.00% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 90.02% | 90.71% |
| CHEMBL2563 | Q9UQL6 | Histone deacetylase 5 | 89.85% | 89.67% |
| CHEMBL5043 | Q6P179 | Endoplasmic reticulum aminopeptidase 2 | 89.60% | 91.81% |
| CHEMBL215 | P09917 | Arachidonate 5-lipoxygenase | 88.87% | 92.68% |
| CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 88.83% | 86.33% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 88.79% | 97.25% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 88.71% | 96.90% |
| CHEMBL2335 | P42785 | Lysosomal Pro-X carboxypeptidase | 88.02% | 100.00% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 87.98% | 96.47% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 87.67% | 95.00% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 87.52% | 97.09% |
| CHEMBL255 | P29275 | Adenosine A2b receptor | 86.77% | 98.59% |
| CHEMBL3476 | O15111 | Inhibitor of nuclear factor kappa B kinase alpha subunit | 86.56% | 95.83% |
| CHEMBL4769 | O95749 | Geranylgeranyl pyrophosphate synthetase | 85.69% | 92.08% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 85.15% | 93.00% |
| CHEMBL3038469 | P24941 | CDK2/Cyclin A | 85.06% | 91.38% |
| CHEMBL2996 | Q05655 | Protein kinase C delta | 84.62% | 97.79% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 84.47% | 96.00% |
| CHEMBL2208 | P49137 | MAP kinase-activated protein kinase 2 | 84.04% | 95.20% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 82.63% | 82.38% |
| CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 82.21% | 94.33% |
| CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 82.08% | 89.50% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 81.68% | 88.42% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 81.54% | 97.14% |
| CHEMBL268 | P43235 | Cathepsin K | 81.46% | 96.85% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 81.44% | 90.17% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 81.21% | 93.03% |
| CHEMBL299 | P17252 | Protein kinase C alpha | 81.13% | 98.03% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 81.02% | 97.64% |
| CHEMBL3891 | P07384 | Calpain 1 | 80.67% | 93.04% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 80.65% | 95.50% |
| CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 80.54% | 85.14% |
| CHEMBL4071 | P08311 | Cathepsin G | 80.14% | 94.64% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 146683690 |
| LOTUS | LTS0198760 |
| wikiData | Q104203034 |